Brief: Herantis Reports Positive FDA Feedback For HER-096 Study
02/06/2026 10:32
BRIEF-Herantis Reports Positive FDA Feedback For HER-096 Study June 2 (Reuters) - Herantis Pharma Oyj HRTIS.HE:
REPORTS POSITIVE U.S. FOOD AND DRUG ADMINISTRATION FEEDBACK AND FINALIZES PHASE 2A STUDY DESIGN FOR HER-096
Further company coverage: HRTIS.HE
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))